Latigo Biotherapeutics Inc.(LTGO)

Medical - Pharmaceuticals · Thousand Oak, CA

$16.26-0.37 (-2.22%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

Operating Cash Flow Yield: N/A

Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.

The operating cash flow yield is N/A as of 2026-10-06T21:02:28.485Z.

Stored calculation inputs

Calculation as of: 2026-10-06T21:02:28.485Z.

Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.

TTM operating cash flow: N/A
Quote market capitalization: 978,090,886

FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840

P/OCF Ratio|FCF Yield|Earnings Yield|EBITDA Yield|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

LTGO Operating Cash Flow Yield Metrics

OPERATING CASH FLOW YIELD

N/A

LTGO Competitors' Operating Cash Flow Yield

LTGO

Latigo Biotherapeutics Inc.

Current

Market Cap

$978.09M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MGTX

MeiraGTx Holdings plc

vs LTGO

Market Cap

$981.66M

Operating Cash Flow Yield

1.39%

TTM Avg

0.99%

3Y Avg

0.99%

5Y Avg

0.99%

PCRX

Pacira BioSciences, Inc.

vs LTGO

Market Cap

$973.93M

Operating Cash Flow Yield

19.27%

TTM Avg

14.96%

3Y Avg

15.37%

5Y Avg

11.65%

LBRX

LB Pharmaceuticals Inc Common Stock

vs LTGO

Market Cap

$982.46M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

VOR

Vor Biopharma Inc.

vs LTGO

Market Cap

$992.14M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PRCT

PROCEPT BioRobotics Corporation

vs LTGO

Market Cap

$996.65M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CGEM

Cullinan Therapeutics, Inc.

vs LTGO

Market Cap

$998.69M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AKTS

Aktis Oncology, Inc.

vs LTGO

Market Cap

$953.81M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

SVRA

Savara Inc.

vs LTGO

Market Cap

$952.91M

Operating Cash Flow Yield

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

IMTX

Immatics N.V.

vs LTGO

Market Cap

$1.01B

Operating Cash Flow Yield

N/A

TTM Avg

1.54%

3Y Avg

13.01%

5Y Avg

70.14%

NAME	MARKET CAP	OPERATING CASH FLOW YIELD	TTM	3Y	5Y
Latigo Biotherapeutics Inc. (LTGO)	$978.09M	N/A	N/A	N/A	N/A
MeiraGTx Holdings plc (MGTX)vs ›	$981.66M	1.39%	0.99%	0.99%	0.99%
Pacira BioSciences, Inc. (PCRX)vs ›	$973.93M	19.27%	14.96%	15.37%	11.65%
LB Pharmaceuticals Inc Common Stock (LBRX)vs ›	$982.46M	N/A	N/A	N/A	N/A
Vor Biopharma Inc. (VOR)vs ›	$992.14M	N/A	N/A	N/A	N/A
PROCEPT BioRobotics Corporation (PRCT)vs ›	$996.65M	N/A	N/A	N/A	N/A
Cullinan Therapeutics, Inc. (CGEM)vs ›	$998.69M	N/A	N/A	N/A	N/A
Aktis Oncology, Inc. (AKTS)vs ›	$953.81M	N/A	N/A	N/A	N/A
Savara Inc. (SVRA)vs ›	$952.91M	N/A	N/A	N/A	N/A
Immatics N.V. (IMTX)vs ›	$1.01B	N/A	1.54%	13.01%	70.14%

Operating Cash Flow Yield Formula & Definition

OCF Yield = TTM Operating Cash Flow / Market Cap

Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Operating Cash Flow Yield: N/A

LTGO Operating Cash Flow Yield Metrics

LTGO Competitors' Operating Cash Flow Yield

Operating Cash Flow Yield Formula & Definition

Related Metrics